Search

everythinglearnresearchcommunity

for

Search:↓

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Hair root sheaths are more common in non-scarring hair loss and help diagnose the type of hair loss.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

IRS premature desquamation is not unique to CCCA and occurs in various scarring alopecias.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

Mutations in certain receptors can cause diseases and offer new treatment options.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

Non-thermal plasma could help hair growth by activating key cell signals.

Multiphoton microscopy can non-invasively tell apart scarring from non-scarring hair loss and could aid in treatment.

Erbium glass laser treatment may help with skin remodeling, reduce inflammation, and improve skin cell maturation.

Non-viral vectors show promise for safe and effective CRISPR/Cas9 gene editing in treating diseases.

Non-myeloablative stem cell transplants are a promising, less toxic option for older or weaker patients, with fewer side effects and good outcomes.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

A woman with hair loss regrew white hair after taking prednisolone.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

Low-dose oral minoxidil effectively treats non-scarring hair loss with some side effects like hypertrichosis and postural hypotension.

Non-immune factors play a significant role in alopecia areata.

Some alternative vitiligo treatments show promise, but none are as effective as psoralens and UVA.

Non-thermal plasma treatment makes mouse skin thicker and increases growth factors without harming the tissue.

XEDAR triggers a specific signaling pathway in cells.

Non-ablative fractional laser treatments have a low risk of side effects in Asian patients.

Isoconazole nitrate stays effective in skin and hair follicles for up to two weeks after use.

Reliable, non-invasive tools are needed for better vitiligo diagnosis.

Managing oxidative stress might help treat low testosterone and related chronic diseases in aging men.

A specific gene variant causes severe skin issues and increases infection risk, requiring careful medical monitoring.

Alpha-melanocyte-stimulating hormone helps manage skin inflammation and protect against UV damage.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Laser treatment improved scalp skin condition with no side effects.